Opinion
Video
Insights on Biomarker Testing in HR+/HER2- Advanced Breast Cancer
Author(s):
Panelists discuss how biomarker testing plays a critical role in hormone receptor–positive, HER2-negative advanced breast cancer, emphasizing the timing of testing, the relevance of specific genomic assays, and the significant impact on prognosis and treatment decisions.
Video content above is prompted by the following:
- Please discuss the role of biomarker testing in hormone receptor–positive, HER2-negative advanced breast cancer.
- At what point during the disease course do you test for biomarkers?
- What are the most clinically relevant genomic tests or biomarker assays, and how do the results influence prognosis and treatment?
Related Videos
Related Content
